Start-up Emulate has secured $36m in funding for the development of its small laboratory chips, designed to replace animal testing in pharmaceutical research. Also participating in the financing were new investors ALS Investment Fund, SciFi VC, and Glass Wall Syndicate, as well as several earlier investors. The company is working with a number of partners on developing chips that can be used by researchers and clinicians around the world who want to test new drugs or treatments without animals. Emulate plans to use the investment to expand the functions of its chips and boost its commercialisation efforts.
Start-up Emulate has secured $36m in funding for the development of its small laboratory chips, designed to replace animal testing in pharmaceutical research. The company is working with a number of partners on developing chips that can be used by researchers and clinicians around the world who want to test new drugs or treatments without animals. Emulate plans to use the investment to expand the functions of its chips and boost its commercialisation efforts.